MedTrace Logo

Effects of Intranasal Oxytocin and Vasopressin on Social Behavior

NCT01296269 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2011-04-08

No results posted yet for this study

Summary

The purpose of this study is to investigate the role of a one-time intranasal administration of the oxytocin, vasopressin, or placebo on prosocial decision making such as cooperation and altruism in a healthy population of student controls.

Conditions

  • Healthy

Interventions

DRUG

Oxytocin

one-time intranasal administration, 24 International Units, 5 puffs for each nostril

DRUG

Arginine Vasopressin

one-time intranasal administration, 20 International Units, 5 puffs in each nostril

DRUG

placebo

contains all the ingredients as in the oxytocin and vasopressin conditions, save for the active ingredient, one time intranasal administration, 5 puffs in each nostril

Sponsors & Collaborators

  • Hebrew University of Jerusalem

    collaborator OTHER

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • David Mankuta, MD · Hadassah University Medical Organization

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-05-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01296269 on ClinicalTrials.gov